معرفی
Claudio Rigatto, MD, FRCPC, MSc, is a Professor in the Department of Internal Medicine at the University of Manitoba’s Max Rady College of Medicine, cross-appointed in the Department of Community Health Sciences. He serves as Academic Director of the Chronic Disease Innovation Centre at Seven Oaks General Hospital. His research focuses on biomarkers of AKI, cardiovascular disease in CKD patients, risk prediction models, and telemonitoring in high-risk CKD populations.
Education includes a Master’s in Clinical Epidemiology (Memorial University, 2001), MD (University of Manitoba, 1993), B.Sc. in Medicine (University of Manitoba, 1997), and a B.A. (Honours) in Physics/Italian from Queen’s University (1988).
Research Themes:
- Telemonitoring in high-risk CKD
- Biomarkers of cardiovascular disease in CKD
- Biomarkers of AKI
- Risk prediction models in kidney disease
Awards:
- Richard Hoeschen Memorial Award (2012, 2016)
- Biomedical Research Fellowship Award (Kidney Foundation of Canada, 1998)
- Biomedical Scholarship (Kidney Foundation of Canada, 2002–2004)
He advises Master’s and PhD students in nephrology and clinical epidemiology. His work bridges clinical nephrology with population health, emphasizing translational research in kidney disease outcomes.
